|
G-Man
|
 |
« on: June 07, 2012, 08:55:52 AM » |
|
I thought I would give just a little insight into why new drugs that come to market are expensive.
I am a doc who works at a drug company in the Pharmacovigilance Dept. Basically we evaluate adverse events that patients experience while on our drugs during clinical trials and after they come to market as well. We are a dept. of 65 people consisting mainly of nurses, pharmacists, and docs, as well as support staff. We all work off of laptops, have either offices or cubes, receive benefits and pensions, and of course have vacation and sick time. The company also does a 5% match on the 401K.
Our dept. makes absolutely no money for the company, instead, we cost the company millions to maintane the above. For example, I just found out that just to data enter the information received into the database costs 9 million per year. We use an outside vendor to do this data entry in order to save money. They can pay the vendor without the costs of pensions, benefits, etc.
The reason for all of this is the insanely strict guidelines that the FDA, and now the EMA (Europes authority), have placed on the companies in order to protect the public. IMO, a good thing, but very expensive. There are other depts. as well, also due to the health authorites, that cost but do not generate money. All of this, on top of the billions spent in research and development, sales, adverstising, travel expenses, clinical trials, and on and on, have to be built into the cost of a pill, or an injection, or a suppository. And drugs manufactured for diseases that are not mainstream have to even more expensive because of the lower volume of use.
|